rs748936034
Variant summary
Our verdict is Uncertain significance. The variant received 3 ACMG points: 3P and 0B. PP3PP4PM5_Supporting
This summary comes from the ClinGen Evidence Repository: The NM_000023.4: c.661C>T variant in SGCA is a missense variant predicted to cause substitution of arginine by cysteine at amino acid 221 (p.Arg221Cys). This variant has been identified in at least five individuals with clinical signs of limb girdle muscular dystrophy (PMID:35416532, 28403181, 30564623; LOVD SGCA_000169) (PP4). The highest minor allele frequency of this variant is 0.0002940 (9/30612 exome chromosomes) in the South Asian population of gnomAD v2.1.1, which is greater than the ClinGen LGMD VCEP threshold (0.00009) for PM2_Supporting (criterion not met). The computational predictor REVEL gives a score of 0.787, which is above the VCEP threshold of ≥0.70, evidence that correlates with impact to SGCA function (PP3). In addition, another missense variant at the same codon, c.662G>C (p.Arg221Pro), has been classified as likely pathogenic for autosomal recessive limb girdle muscular dystrophy by the LGMD VCEP (PM5_Supporting). In summary, this variant cannot be classified as pathogenic nor benign at this time and remains a variant of uncertain significance for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/07/2025): PP4, PP3, PM5_Supporting. LINK:https://erepo.genome.network/evrepo/ui/classification/CA8643859/MONDO:0015152/189
Frequency
Consequence
NM_000023.4 missense
Scores
Clinical Significance
Conservation
Publications
- autosomal recessive limb-girdle muscular dystrophyInheritance: AR Classification: DEFINITIVE Submitted by: ClinGen
- autosomal recessive limb-girdle muscular dystrophy type 2DInheritance: AR Classification: DEFINITIVE, STRONG, SUPPORTIVE Submitted by: Labcorp Genetics (formerly Invitae), Myriad Women’s Health, Laboratory for Molecular Medicine, Orphanet
Genome browser will be placed here
ACMG classification
Our verdict: Uncertain_significance. The variant received 3 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | Exon rank | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
SGCA | NM_000023.4 | c.661C>T | p.Arg221Cys | missense_variant | Exon 6 of 10 | ENST00000262018.8 | NP_000014.1 | |
SGCA | NR_135553.2 | n.697C>T | non_coding_transcript_exon_variant | Exon 6 of 9 | ||||
SGCA | NM_001135697.3 | c.584+596C>T | intron_variant | Intron 5 of 7 | NP_001129169.1 |
Ensembl
Frequencies
GnomAD3 genomes AF: 0.0000394 AC: 6AN: 152114Hom.: 0 Cov.: 31 show subpopulations
GnomAD2 exomes AF: 0.0000597 AC: 15AN: 251336 AF XY: 0.0000736 show subpopulations
GnomAD4 exome AF: 0.0000315 AC: 46AN: 1461788Hom.: 0 Cov.: 32 AF XY: 0.0000413 AC XY: 30AN XY: 727200 show subpopulations
GnomAD4 genome AF: 0.0000394 AC: 6AN: 152114Hom.: 0 Cov.: 31 AF XY: 0.0000538 AC XY: 4AN XY: 74302 show subpopulations
ClinVar
Submissions by phenotype
Autosomal recessive limb-girdle muscular dystrophy type 2D Pathogenic:3Uncertain:3
- -
This submission and the accompanying classification are no longer maintained by the submitter. For more information on current observations and classification, please contact variantquestions@myriad.com. -
This sequence change replaces arginine, which is basic and polar, with cysteine, which is neutral and slightly polar, at codon 221 of the SGCA protein (p.Arg221Cys). This variant is present in population databases (rs748936034, gnomAD 0.03%). This missense change has been observed in individual(s) with clinical features of limb-girdle muscular dystrophy (PMID: 28403181, 32528171; Invitae). In at least one individual the data is consistent with being in trans (on the opposite chromosome) from a pathogenic variant. ClinVar contains an entry for this variant (Variation ID: 452720). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is expected to disrupt SGCA protein function with a positive predictive value of 95%. In summary, the currently available evidence indicates that the variant is pathogenic, but additional data are needed to prove that conclusively. Therefore, this variant has been classified as Likely Pathogenic. -
- -
- -
- -
not provided Pathogenic:1Uncertain:2
- -
The R221C variant in the SGCA gene has been reported previously in the compound heterozygous state, with a second SGCA missense variant, in a Chinese individual with childhood-onset muscle weakness, myalgia, cardiac abnormalities, and elevated creatine kinase (Yu et al., 2017). The R221C variant is observed in 9/30,778 (0.029%) alleles from individuals of South Asian background, in large population cohorts (Lek et al., 2016). The R221C variant is a non-conservative amino acid substitution, which is likely to impact secondary protein structure as these residues differ in polarity, charge, size and/or other properties. This substitution occurs at a position that is conserved in mammals. In silico analysis predicts this variant is probably damaging to the protein structure/function. We interpret R221C as a variant of uncertain significance. -
- -
Autosomal recessive limb-girdle muscular dystrophy Pathogenic:1Uncertain:1
Variant summary: SGCA c.661C>T (p.Arg221Cys) results in a non-conservative amino acid change located in the Sarcoglycan alpha/epsilon second domain (IPR048347) of the encoded protein sequence. Algorithms developed to predict the effect of missense changes on protein structure and function all suggest that this variant is likely to be disruptive. The variant allele was found at a frequency of 6e-05 in 251336 control chromosomes. This frequency is not significantly higher than estimated for a pathogenic variant in SGCA causing Limb-Girdle Muscular Dystrophy, Autosomal Recessive (6e-05 vs 0.002), allowing no conclusion about variant significance. c.661C>T has been observed in individual(s) affected with Limb-Girdle Muscular Dystrophy, Autosomal Recessive (e.g. Stranneheim_2021, Bardhan_2022, Ek_2023, internal data). These data indicate that the variant is likely to be associated with disease. To our knowledge, no experimental evidence demonstrating an impact on protein function has been reported. The following publications have been ascertained in the context of this evaluation (PMID: 32875335, 35416532, 37273706, 33726816, 32528171, 30764848, 28403181). ClinVar contains an entry for this variant (Variation ID: 452720). Based on the evidence outlined above, the variant was classified as likely pathogenic. -
The NM_000023.4: c.661C>T variant in SGCA is a missense variant predicted to cause substitution of arginine by cysteine at amino acid 221 (p.Arg221Cys). This variant has been identified in at least five individuals with clinical signs of limb girdle muscular dystrophy (PMID: 35416532, 28403181, 30564623; LOVD SGCA_000169) (PP4). The highest minor allele frequency of this variant is 0.0002940 (9/30612 exome chromosomes) in the South Asian population of gnomAD v2.1.1, which is greater than the ClinGen LGMD VCEP threshold (0.00009) for PM2_Supporting (criterion not met). The computational predictor REVEL gives a score of 0.787, which is above the VCEP threshold of ≥0.70, evidence that correlates with impact to SGCA function (PP3). In addition, another missense variant at the same codon, c.662G>C (p.Arg221Pro), has been classified as likely pathogenic for autosomal recessive limb girdle muscular dystrophy by the LGMD VCEP (PM5_Supporting). In summary, this variant cannot be classified as pathogenic nor benign at this time and remains a variant of uncertain significance for autosomal recessive limb girdle muscular dystrophy based on the ACMG/AMP criteria applied, as specified by the ClinGen LGMD VCEP (LGMD VCEP specifications version 1.0.0; 01/07/2025): PP4, PP3, PM5_Supporting. -
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at